14 March 2019
The PLEASE 5+ study will include the approximately 300 patients with chronic Lyme-associated symptoms who have been part of the previous PLEASE trial by the same Radboudumc researchers (N Engl J Med 2016). The current project will assess patients’ long-term experiences with both regular and complementary therapies, as well as the impact of their disease on quality of life and work. The role of patients in initiating, designing and executing the PLEASE 5+ study is unprecedented.
Bart-Jan Kullberg is member of theme Infectious diseases and global health.
Bart-Jan Kullberg has received the ZonMw Medical Inspirator prize 2019. This prize for the most inspiring collaboration between researchers and patients has been awarded both by a scientific jury and by public voting.
The PLEASE 5+ study will include the approximately 300 patients with chronic Lyme-associated symptoms who have been part of the previous PLEASE trial by the same Radboudumc researchers (N Engl J Med 2016). The current project will assess patients’ long-term experiences with both regular and complementary therapies, as well as the impact of their disease on quality of life and work. The role of patients in initiating, designing and executing the PLEASE 5+ study is unprecedented.
Bart-Jan Kullberg is member of theme Infectious diseases and global health.
-
Want to know more about these subjects? Click on the buttons below for more news.
Related news items

Q fever antibody does not predict disease progression
6 July 2021 Joint study by Radboudumc, Jeroen Bosch Hospital and UMC Utrecht. read more
First Dutch professor of infectious disease outbreaks at Radboud university medical center
4 June 2021 Chantal Bleeker-Rovers about research on coronavirus, Q fever and other infectious diseases outbreaks read more
Trained immunity: a tool for reducing susceptibility to and the severity of SARS-CoV-2 infection
17 February 2021 In a review in Cell Mihai Netea, Frank van de Veerdonk, Reinout van Crevel and Jorge Dominguez Andres propose that induction of trained immunity by whole-microorganism vaccines may represent an important tool for reducing susceptibility to and severity of SARS-CoV-2. read more
Invasive fungal infections in influenza and COVID-19
8 July 2020 The Aspergillus fungus is found in the lungs of many COVID patients. A parallel occurs with influenza patients, who often develop a serious fungal infection. Although such a serious fungal infection seems to occur less frequently in COVID-patients, alertness remains necessary, read more
Trained immunity: a tool for reducing susceptibility to and the severity of SARS-CoV-2 infection
29 June 2020 In a review in Cell Mihai Netea, Frank van de Veerdonk, Reinout van Crevel and Jorge Dominguez Andres propose that induction of trained immunity by whole-microorganism vaccines may represent an important tool for reducing susceptibility to and severity of SARS-CoV-2. read more